The Role of Butyrate, A Histone Deacetylase Inhibitor in Diabetes Mellitus: Experimental Evidence for Therapeutic Intervention

References

• Van Belle TL , CoppietersKT , Von HerrathMG . Type 1 diabetes: etiology, immunology, and therapeutic strategies . Physiol. Rev.91 ( 1 ), 79 – 118 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Khan S , JenaG , TikooK , KumarV . Valproate attenuates the proteinuria, podocyte and renal injury by facilitating autophagy and inactivation of NF-kappaB/iNOS signaling in diabetic rat . Biochimie.110 , 1 – 16 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Pirola L , BalcerczykA , OkabeJ , El-OstaA . Epigenetic phenomena linked to diabetic complications . Nat. Rev. Endocrinol.6 ( 12 ), 665 – 675 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Ilonen J , VaaralaO , AkerblomHK , KnipM . Environmental factors and primary prevention in type 1 diabetes . Pediatr. Endocrinol. Diabetes Metab.15 ( 4 ), 227 – 232 ( 2009 ).
   PubMedGoogle Scholar
• Miao F , ChenZ , ZhangLet al. Profiles of epigenetic histone post-translational modifications at type 1 diabetes susceptible genes . J. Biol. Chem.287 ( 20 ), 16335 – 16345 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Volkmar M , DedeurwaerderS , CunhaDAet al. DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients . EMBO J.31 ( 6 ), 1405 – 1426 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Bramswig NC , KaestnerKH . Epigenetics and diabetes treatment: an unrealized promise?Trends Endocrinol. Metab.23 ( 6 ), 286 – 291 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Gray SG , De MeytsP . Role of histone and transcription factor acetylation in diabetes pathogenesis . Diabetes Metab. Res. Rev.21 ( 5 ), 416 – 433 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Lawless MW , NorrisS , O’byrneKJ , GraySG . Targeting histone deacetylases for the treatment of disease . J. Cell. Mol. Med.13 ( 5 ), 826 – 852 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Keating ST , El-OstaA . Epigenetic changes in diabetes . Clin. Genet.84 ( 1 ), 1 – 10 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Karpac J , JasperH . Metabolic homeostasis: HDACs take center stage . Cell145 ( 4 ), 497 – 499 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Pham TX , LeeJ . Dietary regulation of histone acetylases and deacetylases for the prevention of metabolic diseases . Nutrients4 ( 12 ), 1868 – 1886 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kariz S , PetrovicD . Minor association of kinase insert domain-containing receptor gene polymorphism (rs2071559) with myocardial infarction in Caucasians with type 2 diabetes mellitus: case-control cross-sectional study . Clin. Biochem.47 ( 16–17 ), 192 – 196 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Petrovic D . Candidate genes for proliferative diabetic retinopathy . BioMed Res. Int.2013 , 540416 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Christensen DP , DahllofM , LundhMet al. Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus . Mol. Med.17 ( 5–6 ), 378 – 390 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Mihaylova MM , VasquezDS , RavnskjaerKet al. Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis . Cell145 ( 4 ), 607 – 621 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Aher JS , KhanS , JainS , TikooK , JenaG . Valproate ameliorates thioacetamide-induced fibrosis by hepatic stellate cell inactivation . Hum. Exp. Toxicol.34 ( 1 ), 44 – 55 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Khan S , JenaG . Sodium valproate, a histone deacetylase inhibitor ameliorates cyclophosphamide-induced genotoxicity and cytotoxicity in the colon of mice . J. Basic Clin. Physiol. Pharmacol.1 – 11 ( 2014 ).
   PubMedGoogle Scholar
• Villeneuve LM , NatarajanR . The role of epigenetics in the pathology of diabetic complications . Am. J. Physiol. Renal Physiol.299 ( 1 ), F14 – F25 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Lee HB , NohH , SeoJY , YuMR , HaH . Histone deacetylase inhibitors: a novel class of therapeutic agents in diabetic nephropathy . Kidney Int. Suppl. ( 106 ), S61 – S66 ( 2007 ).
   PubMedGoogle Scholar
• Chou DH , HolsonEB , WagnerFFet al. Inhibition of histone deacetylase 3 protects beta cells from cytokine-induced apoptosis . Chem. Biol.19 ( 6 ), 669 – 673 ( 2012 ).
   PubMedGoogle Scholar
• Lenoir O , FlosseauK , MaFXet al. Specific control of pancreatic endocrine beta- and delta-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC9 . Diabetes60 ( 11 ), 2861 – 2871 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Lewis EC , BlaabjergL , StorlingJet al. The oral histone deacetylase inhibitor ITF2357 reduces cytokines and protects islet beta cells in vivo and in vitro . Mol. Med.17 ( 5–6 ), 369 – 377 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Lundh M , ChristensenDP , Damgaard NielsenMet al. Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced beta cell apoptosis in INS-1 cells and dispersed primary islets from rats and are differentially regulated in the islets of type 1 diabetic children . Diabetologia55 ( 9 ), 2421 – 2431 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Glozak MA , SenguptaN , ZhangX , SetoE . Acetylation and deacetylation of non-histone proteins . Gene363 , 15 – 23 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Mutskov V , RaakaBM , FelsenfeldG , GershengornMC . The human insulin gene displays transcriptionally active epigenetic marks in islet-derived mesenchymal precursor cells in the absence of insulin expression . Stem Cells25 ( 12 ), 3223 – 3233 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Kaiser C , JamesSR . Acetylation of insulin receptor substrate-1 is permissive for tyrosine phosphorylation . BMC Biol.2 , 23 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Offield MF , JettonTL , LaboskyPAet al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum . Development122 ( 3 ), 983 – 995 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Meier BC , WagnerBK . Inhibition of HDAC3 as a strategy for developing novel diabetes therapeutics . Epigenomics6 ( 2 ), 209 – 214 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Weems J , OlsonAL . Class II histone deacetylases limit GLUT4 gene expression during adipocyte differentiation . J. Biol. Chem.286 ( 1 ), 460 – 468 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Weems JC , GrieselBA , OlsonAL . Class II histone deacetylasesdownregulate GLUT4 transcription in response to increased cAMP signaling in cultured adipocytes and fasting mice . Diabetes61 ( 6 ), 1404 – 1414 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Canani RB , CostanzoMD , LeoneL , PedataM , MeliR , CalignanoA . Potential beneficial effects of butyrate in intestinal and extraintestinal diseases . World J. Gastroenterol.17 ( 12 ), 1519 – 1528 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Gao Z , YinJ , ZhangJet al. Butyrate improves insulin sensitivity and increases energy expenditure in mice . Diabetes58 ( 7 ), 1509 – 1517 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Donohoe DR , CollinsLB , WaliA , BiglerR , SunW , BultmanSJ . The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation . Mol. Cell48 ( 4 ), 612 – 626 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Li N , HatchM , WasserfallCHet al. Butyrate and type 1 diabetes mellitus: can we fix the intestinal leak? J. Pediatr. Gastroenterol. Nutr. 51 ( 4 ), 414 – 417 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• BerniCanani R , Di CostanzoM , LeoneL . The epigenetic effects of butyrate: potential therapeutic implications for clinical practice . Clin. Epigenet.4 ( 1 ), 4 ( 2012 ).
   PubMedGoogle Scholar
• Goicoa S , AlvarezS , RicordiC , InverardiL , Dominguez-BendalaJ . Sodium butyrate activates genes of early pancreatic development in embryonic stem cells . Cloning Stem Cells8 ( 3 ), 140 – 149 ( 2006 ).
   PubMedGoogle Scholar
• Khan S , JenaGB . Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38/ERK MAPK and apoptotic pathways: Study in juvenile diabetic rat . Chem. Biol. Interact.213C , 1 – 12 ( 2014 ).
   Google Scholar
• Anderson JW , BairdP , DavisRHJret al. Health benefits of dietary fiber . Nutr. Rev.67 ( 4 ), 188 – 205 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Anderson JW , ZeiglerJA , DeakinsDAet al. Metabolic effects of high-carbohydrate, high-fiber diets for insulin-dependent diabetic individuals . Am. J. Clin. Nutr.54 ( 5 ), 936 – 943 ( 1991 ).
   PubMed Web of Science ®Google Scholar
• Jakobsdottir G , XuJ , MolinG , AhrneS , NymanM . High-fat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects . PLoS ONE8 ( 11 ), e80476 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Yadav H , LeeJH , LloydJ , WalterP , RaneSG . Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion . J. Biol. Chem.288 ( 35 ), 25088 – 25097 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• De Goffau MC , FuentesS , Van Den BogertBet al. Aberrant gut microbiota composition at the onset of type 1 diabetes in young children . Diabetologia57 ( 8 ), 1569 – 1577 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Vaarala O . Human intestinal microbiota and type 1 diabetes . Curr. Diab. Rep.13 ( 5 ), 601 – 607 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• De Goffau MC , LuopajarviK , KnipMet al. Fecal microbiota composition differs between children with beta-cell autoimmunity and those without . Diabetes62 ( 4 ), 1238 – 1244 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Furusawa Y , ObataY , FukudaSet al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells . Nature504 ( 7480 ), 446 – 450 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Khan S , JenaG . Sodium butyrate, a HDAC inhibitor ameliorates eNOS, iNOS and TGF-beta1-induced fibrogenesis, apoptosis and DNA damage in the kidney of juvenile diabetic rats . Food Chem. Toxicol.73c , 127 – 139 ( 2014 ).
   Google Scholar
• Mosley AL , OzcanS . The pancreatic duodenal homeobox-1 protein (Pdx-1) interacts with histone deacetylases Hdac-1 and Hdac-2 on low levels of glucose . J. Biol. Chem.279 ( 52 ), 54241 – 54247 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Haumaitre C , LenoirO , ScharfmannR . Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors . Mol. Cell. Biol.28 ( 20 ), 6373 – 6383 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Chen T-H , ChenW-M , HsuK-H , KuoC-D , HungS-C . Sodium butyrate activates ERK to regulate differentiation of mesenchymal stem cells . Biochem. Biophys. Res. Commun.355 ( 4 ), 913 – 918 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Aramata S , HanSI , YasudaK , KataokaK . Synergistic activation of the insulin gene promoter by the beta-cell enriched transcription factors MafA, Beta2, and Pdx1 . Biochim. Biophys. Acta1730 ( 1 ), 41 – 46 ( 2005 ).
   PubMedGoogle Scholar
• Oetjen E , BlumeR , CiernyIet al. Inhibition of MafA transcriptional activity and human insulin gene transcription by interleukin-1beta and mitogen-activated protein kinase kinasekinase in pancreatic islet beta cells . Diabetologia50 ( 8 ), 1678 – 1687 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Lundh M , ChristensenDP , RasmussenDNet al. Lysine deacetylases are produced in pancreatic beta cells and are differentially regulated by proinflammatory cytokines . Diabetologia53 ( 12 ), 2569 – 2578 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Mosley AL , OzcanS . Glucose regulates insulin gene transcription by hyperacetylation of histone h4 . J. Biol. Chem.278 ( 22 ), 19660 – 19666 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Haberland M , MontgomeryRL , OlsonEN . The many roles of histone deacetylases in development and physiology: implications for disease and therapy . Nat. Rev. Genet.10 ( 1 ), 32 – 42 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Hara N , AlkananiAK , DinarelloCA , ZiprisD . Histone deacetylase inhibitor suppresses virus-induced proinflammatory responses and type 1 diabetes . J. Mol. Med. (Berl.)92 ( 1 ), 93 – 102 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Christensen DP , GysemansC , LundhMet al. Lysine deacetylase inhibition prevents diabetes by chromatin-independent immunoregulation and beta-cell protection . Proc. Natl Acad. Sci. USA111 ( 3 ), 1055 – 1059 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• He YW , WangHS , ZengJet al. Sodium butyrate inhibits interferon-gamma induced indoleamine 2,3-dioxygenase expression via STAT1 in nasopharyngeal carcinoma cells . Life Sci.93 ( 15 ), 509 – 515 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Ohira H , FujiokaY , KatagiriCet al. Butyrate attenuates inflammation and lipolysis generated by the interaction of adipocytes and macrophages . J. Atheroscler. Thrombos.20 ( 5 ), 425 – 442 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Place RF , NoonanEJ , GiardinaC M . HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha . Biochem. Pharmacol.70 ( 3 ), 394 – 406 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Song M , XiaB , LiJ . Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1beta, and nuclear factor kappaB in trinitrobenzenesulphonic acid induced colitis in rats . Postgrad. Med. J.82 ( 964 ), 130 – 135 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Kanika G , KhanS , JenaG . Sodium butyrate ameliorates L-arginine-induced pancreatitis and associated fibrosis in wistar rat: Role of inflammation and nitrosative stress . J. Biochem. Mol. Toxicol. ( 2015 ) ( In press ).
   PubMed Web of Science ®Google Scholar
• Dayeh T , VolkovP , SaloSet al. Genome-wide DNA methylation analysis of human pancreatic islets from type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion . PLoS Genet.10 ( 3 ), e1004160 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Sandovici I , HammerleCM , OzanneSE , ConstanciaM . Developmental and environmental epigenetic programming of the endocrine pancreas: consequences for type 2 diabetes . Cell. Mol. Life Sci.70 ( 9 ), 1575 – 1595 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Sparling DP , GrieselBA , WeemsJ , OlsonAL . GLUT4 enhancer factor (GEF) interacts with MEF2A and HDAC5 to regulate the GLUT4 promoter in adipocytes . J. Biol. Chem.283 ( 12 ), 7429 – 7437 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Mcgee SL , Van DenderenBJ , HowlettKFet al. AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5 . Diabetes57 ( 4 ), 860 – 867 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Raichur S , TehSH , OhwakiKet al. Histone deacetylase 5 regulates glucose uptake and insulin action in muscle cells . J. Mol. Endocrinol.49 ( 3 ), 203 – 211 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Oiso H , FurukawaN , SuefujiMet al. The role of class I histone deacetylase (HDAC) on gluconeogenesis in liver . Biochem. Biophys. Res. Commun.404 ( 1 ), 166 – 172 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Sun C , ZhouJ . Trichostatin A improves insulin stimulated glucose utilization and insulin signaling transduction through the repression of HDAC2 . Biochem. Pharmacol.76 ( 1 ), 120 – 127 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Rumberger JM , ArchJR , GreenA . Butyrate and other short-chain fatty acids increase the rate of lipolysis in 3T3-L1 adipocytes . PeerJ.2 , e611 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Hu GX , ChenGR , XuH , GeRS , LinJ . Activation of the AMP activated protein kinase by short-chain fatty acids is the main mechanism underlying the beneficial effect of a high fiber diet on the metabolic syndrome . Med. Hypotheses74 ( 1 ), 123 – 126 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Henagan TM , StefanskaB , FangZet al. Sodium butyrate epigenetically modulates high fat diet-induced skeletal muscle mitochondrial adaptation, obesity and insulin resistance through nucleosome positioning . Br. J. Pharmacol. doi: https://doi.org/10.1111/bph . 13058 ( 2015 ) ( Epub ahead of print ).
   Web of Science ®Google Scholar
• Endo H , NiiokaM , KobayashiN , TanakaM , WatanabeT . Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis . PLoS ONE8 ( 5 ), e63388 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Talchai C , XuanS , LinHV , SusselL , AcciliD . Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure . Cell150 ( 6 ), 1223 – 1234 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Guo S , DaiC , GuoMet al. Inactivation of specific beta cell transcription factors in type 2 diabetes . J. Clin. Invest.123 ( 8 ), 3305 – 3316 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Li HP , ChenX , LiMQ . Butyrate alleviates metabolic impairments and protects pancreatic beta cell function in pregnant mice with obesity . Int. J. Clin. Exp. Pathol.6 ( 8 ), 1574 – 1584 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Chakrabarti SK , FrancisJ , ZiesmannSM , GarmeyJC , MirmiraRG . Covalent histone modifications underlie the developmental regulation of insulin gene transcription in pancreatic beta cells . J. Biol. Chem.278 ( 26 ), 23617 – 23623 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Bramswig NC , KaestnerKH . Transcriptional and epigenetic regulation in human islets . Diabetologia57 ( 3 ), 451 – 454 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Lindholm CR , ErtelRL , BauwensJD , SchmuckEG , MulliganJD , SaupeKW . A high-fat diet decreases AMPK activity in multiple tissues in the absence of hyperglycemia or systemic inflammation in rats . J. Physiol. Biochem.69 ( 2 ), 165 – 175 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Vinolo MA , RodriguesHG , FestucciaWTet al. Tributyrin attenuates obesity-associated inflammation and insulin resistance in high-fat-fed mice . Am. J. Physiol. Endocrinol. Metab.303 ( 2 ), E272 – E282 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Gao Z , HeQ , PengB , ChiaoPJ , YeJ . Regulation of nuclear translocation of HDAC3 by IkappaBalpha is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor gamma function . J. Biol. Chem.281 ( 7 ), 4540 – 4547 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Li D , WangX , RenWet al. High expression of liver histone deacetylase 3 contributes to high-fat-diet-induced metabolic syndrome by suppressing the PPAR-gamma and LXR-alpha-pathways in E3 rats . Mol. Cell. Endocrinol.344 ( 1–2 ), 69 – 80 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Masui R , SasakiM , FunakiYet al. G protein-coupled receptor 43 moderates gut inflammation through cytokine regulation from mononuclear cells . Inflamm. Bowel Dis.19 ( 13 ), 2848 – 2856 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Remely M , AumuellerE , MeroldCet al. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity . Gene537 ( 1 ), 85 – 92 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kaji I , KarakiS , KuwaharaA . Short-chain fatty acid receptor and its contribution to glucagon-like peptide-1 release . Digestion89 ( 1 ), 31 – 36 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Lin HV , FrassettoA , KowalikEJJret al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms . PLoS ONE7 ( 4 ), e35240 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Brownawell AM , CaersW , GibsonGRet al. Prebiotics and the health benefits of fiber: current regulatory status, future research, and goals . J. Nutr.142 ( 5 ), 962 – 974 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kim SW , HookerJM , OttoNet al. Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET . Nucl. Med. Biol.40 ( 7 ), 912 – 918 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• MattaceRaso G , SimeoliR , RussoRet al. Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet . PLoS ONE8 ( 7 ), e68626 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Roda A , SimoniP , MagliuloMet al. A new oral formulation for the release of sodium butyrate in the ileo-cecal region and colon . World J. Gastroenterol.13 ( 7 ), 1079 – 1084 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Krokowicz L , StojcevZ , KaczmarekBFet al. Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis-a prospective randomized study . Int. J. Colorectal Dis.29 ( 3 ), 387 – 393 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Sekhavat A , SunJM , DavieJR . Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate . Biochem. Cell Biol.85 ( 6 ), 751 – 758 ( 2007 ).
   PubMedGoogle Scholar
• Khan S , JenaG , TikooK . Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat . Exp. Mol. Pathol.98 ( 2 ), 230 – 239 ( 2015 ).
   PubMed Web of Science ®Google Scholar